Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Cash from Discontinued Operations (2023 - 2024)

Historic Cash from Discontinued Operations for Mimedx (MDXG) over the last 2 years, with Q4 2024 value amounting to $1000.0.

  • Mimedx's Cash from Discontinued Operations fell 9989.87% to $1000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $1000.0, marking a year-over-year decrease of 9821.43%. This contributed to the annual value of -$930000.0 for FY2024, which is 8860.57% up from last year.
  • Per Mimedx's latest filing, its Cash from Discontinued Operations stood at $1000.0 for Q4 2024, which was down 9989.87% from -$1000.0 recorded in Q3 2024.
  • In the past 5 years, Mimedx's Cash from Discontinued Operations registered a high of $987000.0 during Q4 2023, and its lowest value of -$4.6 million during Q1 2023.